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Introduction Immunoglobulin subtype G4-related disease (IgG4-RD) is a ﬁbroinﬂammatory disease of unknown etiology, with manifestations involving nearly every organ
system. Its association with foreign bodies is not established. Here, we present a novel
case of IgG4-RD in response to foreign body injection.
Case Description A 58-year-old woman presented with history of persistent left facial
pain, xerophthalmia, blurred vision, and trismus. The patient’s medical history was
signiﬁcant for left-sided temporomandibular joint (TMJ) reconstruction with silicone
injection into the joint. Magnetic resonance imaging revealed a lesion in the left skull
base. Biopsies demonstrated the cardinal histopathological features of IgG4-RD. The
patient was treated with a tapering dose of prednisolone followed by rituximab,
resulting in tumor shrinkage and resolution of her symptoms.
Discussion This is the ﬁrst reported case of IgG4-RD potentially precipitated by a
foreign body, in this case injected silicone into the TMJ. The pathogenesis and etiology of
IgG4-RD is still not fully elucidated, but allergic and reactive inﬂammatory reactions
have been implicated in the disease process. This case report should raise the idea of
reactive foreign bodies as a causative agent for IgG4-RD.

Introduction
Immunoglobulin subtype G4-related disease (IgG4-RD) is a
ﬁbroinﬂammatory disease of unknown etiology, which may
present with a wide array of manifestations, with reported
cases involving nearly every organ system. IgG4-RD is a
diagnosis that is becoming increasingly recognized by the
medical community. One of the most common and welldescribed manifestations is type 1 autoimmune pancreatitis.
Additionally, over time, many previously described diseases
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have been recently reclassiﬁed. For example, Mikulicz syndrome, and Küttner tumor have been recognized as part of
the spectrum of IgG4-RD.1 Often with IgG4-RD, the presentations are so similar to that of a neoplasm that they are
surgically managed as such. In the case of Küttner tumor,
excision is fortunately both diagnostic and therapeutic. Delayed or missed diagnosis, however, can result in signiﬁcant
morbidity and mortality. This is evident when considering
patients who have been diagnosed with type 1 autoimmune
pancreatitis only after undergoing a Whipple procedure.
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Despite the wide array of presentations and locations of
disease, there are clinical, laboratory, and histological characteristics that link the many disparate manifestations.2
Clinically, the lesions are often tumefactive and have been
described as arising in multiple sites across the body in both
synchronous and metachronous patterns.2 There is also often
rapid clinical response to immunosuppression. This is typically achieved with corticosteroids, though concerns about
long-term steroid use have prompted investigation into alternative therapies including the use of mycophenolate
mofetil.3
In approximately 80% of patients with suspected IgG4-RD,
laboratory testing reveals serum IgG4 levels greater than 135
mg/dL. Elevated serum IgG4 is not by itself sufﬁciently
speciﬁc for a diagnosis of IgG4-RD as there can be elevated
levels in other inﬂammatory diseases.4 Conversely, some
patients with classic histologic features have negative serum
values, raising concerns about the sensitivity of this test. For
example, in a case series of 11 patients, 6 had normal serum
IgG4 levels; however out of these patients, 5 demonstrated
positive IgG4 immunostaining.5
The diagnosis of IgG4-RD is primarily made with biopsy,
demonstrating characteristic histopathological features and
immunohistochemical staining. There are three histopathological ﬁndings which are highly suggestive of IgG4-RD, but
could be found in other pathologies; these are dense lymphoplasmacytic inﬁltrate rich in IgG4, storiform pattern of
ﬁbrosis, and obliterative phlebitis.2 Other potential features
of disease include nonobliterative phlebitis and increased
eosinophils, though these are neither sensitive nor speciﬁc in
isolation.2 It is important to ascertain the presence of granulomas, necrosis, giant cells, and neutrophils as these are
suggestive of other underlying diseases such as granulomatosis with polyangiitis.2
In addition, specimens should be examined using immunohistochemistry. According to the diagnostic criterion presented by Pieringer et al, an IgG4/IgG ratio of greater than 40%
is highly suggestive of IgG4-RD.6 Visualization of more than
10 IgG4 cells in a high power ﬁeld is also highly suggestive of
IgG4-RD. The IgG4/IgG ratio is thought to be more useful as
other inﬂammatory pathologies may present with increased
IgG4 cells in a high power ﬁeld due to the overall increase in
plasma cells. Looking at the ratio is thus more speciﬁc to IgG4RD.2
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Case Review
Here, we present a case of a 58-year-old woman who presented to our practice in 2011 with persistent left face pain,
xerophthalmia, and blurred vision. She also had left proptosis,
left periorbital edema, and trismus. These symptoms were
believed to be caused by a chronically expanding mass in her
infratemporal fossa with some orbital involvement. She is
morbidly obese (body mass index > 40) and has a history of
hypertension and diabetes mellitus type II as well as temporomandibular joint (TMJ) dysfunction. Notably, the patient
underwent TMJ reconstruction and received silicone injections to the left TMJ in 2000.
In 2007, the patient began manifesting symptoms of left
periorbital edema and proptosis. It is suspected that the
lesion is a reaction to the silicone injection given the location
and timing. On imaging (►Fig. 1), a lesion in the left infratemporal fossa, masticator, and buccal space with extension
into the maxillary sinus and orbit is noted. The largest margin
of the mass measures 5 cm. The mass had been biopsied in
2008 and showed chronic granulation tissue. The lesion
decreased in size in response to treatment with prednisone.
Over the next several years, this mass was monitored closely,
including several biopsies.
Histology strongly suggested an underlying inﬂammatory
etiology; however, for several years the pathology reports
had trouble identifying the exact inﬂammatory modulators.
Clinical correlation suggested an inﬂammatory cause of
symptoms as it manifested in the area, where the patient
received the silicone injection, the tumor took up 18F-ﬂuorodeoxyglucose, the tumor responded to acute treatment with
prednisone, and all of the pathology reports showed ﬁbrotic
tissue with lymphoplasmacytic inﬁltrate.

Material and Methods
This is a case report of a patient seen by our practice with
suspected IgG4-RD of the head and neck. As well as a
literature review utilizing PubMed.

Setting
The New York Head and Neck Institute (NYHNI) is a fullservice otolaryngology department at Lenox Hill Hospital,
part of the North Shore Long Island Jewish Health System. The
NYHNI serves a diverse patient population with a wide range
of head and neck diseases in a tertiary hospital setting.
Journal of Neurological Surgery Reports
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Fig. 1 A transverse T2-weighted MRI of the skull base showing the
lesion expressed as the region of high signal intensity in the left
infratemporal fossa (red arrow). MRI, magnetic resonance imaging.
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Fig. 2 A high-power Mallory trichrome stain demonstrates storiform
ﬁbrosis.

Fig. 4 High-power Verhoeff elastic staining, demonstrating obliterative phlebitis.

In 2014, the patient was diagnosed with probable IgG4-RD
based on a conﬂuence of clinical presentation and biopsy,
including histology. The biopsy revealed a lymphoplasmacytic inﬁltrate, storiform ﬁbrosis (►Fig. 2 and 3), obliterative
phlebitis (►Fig. 4), and an IgG4/IgG ratio of greater than 30%
in plasma cells (►Fig. 5), which are the hallmarks of IgG4-RD.
It is important to correlate these ﬁndings to the clinical and
hematological markers, because focally many disease entities
may mimic IgG4-RD. Even in the presence of pathognomonic
histological features, blood levels of IgG4 should be evaluated.
While other disease entities can resemble IgG4-RD on isolated sections, when these histologic ﬁndings are found in the
setting of elevated serum IgG4, a diagnosis of probable IgG4RD can be made. The patient did not have elevated serum IgG4
levels; however, as per the criteria proposed by Pieringer et al
(►Fig. 6), she has probable IgG4-RD despite normal serum
IgG4 levels.
The established treatment of IgG4-RD, like most inﬂammatory diseases, is corticosteroids. The patient received a
tapering dose of prednisolone. Long-term corticosteroid usage presents a multitude of problems, including Cushing

syndrome and Cushing-like presentations. As a result, prednisolone is administered via a tapering dose. The prednisolone did not signiﬁcantly shrink the lesion as much as we had
hoped and thus the patient was also started on rituximab. She
received one dose every month and responded well with
signiﬁcant tumor shrinkage and resolution of her complaints.
Currently, the patient is receiving one dose every 2 months.
Rituximab is a monoclonal antibody toward CD-20, a marker
present on B-cells precursors as well as mature B-lymphocytes. The function is to inhibit the further production of
antibodies such as IgG4.

When clinical course suggests potential IgG4-RD yet serum
levels are normal, biopsy criterion should be evaluated as
they are considered a more powerful measure than serum
levels.2 Patients with IgG4-RD typically demonstrate IgG4/
IgG ratios of > 40%. These must be correlated with overall
sample IgG4 cells per high powered ﬁeld. Our patient demonstrated the three cardinal histopathological features of

Fig. 3 A high power H&E image from our patient showing storiform
ﬁbrosis and pale staining plasma cells. H&E, hematoxylin and eosin.

Fig. 5 A high-power IgG4 stain, which demonstrates more than 30% of
plasma cells have IgG4. IgG4, immunoglobulin subtype G4.

Discussion
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Fig. 6 IgG4-related disease: an orphan disease with many faces. (Reprinted with permission from Pieringer et al.)6 IgG4, immunoglobulin subtype
G4-related disease.

IgG4-RD: (1) lymphoplasmacytic inﬁltrate, (2) obliterative
phlebitis, and (3) storiform ﬁbrosis. However, her IgG4 þ /
IgG ratio was > 30%, making her a borderline patient.
Clinical and histopathological correlation must be made to
differentiate from other immune-mediated diseases such as
rheumatoid arthritis and Castleman disease. It is important
when considering a diagnosis of IgG4-RD, particularly in a
patient with an atypical presentation, to rule out immunemodulated inﬂammatory diseases, low-grade lymphoma,
and organ-speciﬁc malignancies. Our patient underwent a
bone marrow biopsy to rule out plasma cell dyscrasia. Elevated plasma cells were noted, but the levels of less than 10%
indicated that there was no amyloid reaction.
To date, there is limited published data on head and neck
manifestations of IgG4-RD. The majority of cases reported
concern lacrimal glands, salivary glands, and isolated or
concurrent cervical lymph node involvement; however,
case reports involving disease in the sinonasal cavity and
skull base are beginning to emerge as the disease is becoming
better known. These are more likely than other manifestations of the disease to lack the typical histologic patterns of
storiform ﬁbrosis and obliterative phlebitis. Rarely, IgG4-RD
can present as a tumor in the head and neck.7–11

eliminate the need for risky unnecessary surgeries, which are
associated with substantial morbidity. For example, autoimmune pancreatitis is often not diagnosed until the patient
has undergone a Whipple surgery, which greatly increases
morbidity and mortality over the treatment with
prednisone.
In the past, diagnosis has been delayed as not much was
understood about IgG4-RD. Hopefully with the gained understanding, patients can be diagnosed earlier to prevent
subsequent surgeries, like in our patient who underwent
many biopsies before the ultimate diagnosis.
While difﬁcult to prove, it is conceivable that the patient
experienced IgG4-RD in response to her silicone injection.
Injectables have been known to cause an inﬂammatory
response and other injectables have been indicated in IgG4RD; however, this would be the ﬁrst case of silicone as a
causative agent.
Taking together the imaging, history of disease, and histopathological results, this case report should raise the clinical possibility of reactive foreign bodies as a causative agent
for IgG4-RD. This case report should be informative for the
head and neck surgeon as this disease entity is becoming
increasingly recognized.

Conclusion
Given the appropriate clinical picture, histological ﬁndings,
and serum levels may point us in the direction of IgG4-RD.
The diagnosis of this disease is very important as it can
Journal of Neurological Surgery Reports
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